共 50 条
- [41] Phase I/II docetaxel plus concurrent hyperfractionated radiotherapy in locally advanced unresectable head and neck cancer (TAX.ES1.102 study) CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (04): : 254 - 260
- [42] Phase I/II docetaxel plus concurrent hyperfractionated radiotherapy in locally advanced unresectable head and neck cancer (TAX.ES1.102 study) Clinical and Translational Oncology, 2011, 13 : 254 - 260
- [49] Update of a Phase 2 Study of Definitive Radiation Therapy With Concurrent Docetaxel and Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 480 - 481
- [50] Dose escalation of daily carboplatin concurrent with accelerated radiation by delayed concomitant boost for locally advanced head and neck cancer INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S372 - S373